[go: up one dir, main page]

ME01521B - Antibakterijski kinolinski derivati - Google Patents

Antibakterijski kinolinski derivati

Info

Publication number
ME01521B
ME01521B MEP-2013-43A MEP4313A ME01521B ME 01521 B ME01521 B ME 01521B ME P4313 A MEP4313 A ME P4313A ME 01521 B ME01521 B ME 01521B
Authority
ME
Montenegro
Prior art keywords
quinoline derivatives
antibacterial quinoline
antibacterial
solubles
oxides
Prior art date
Application number
MEP-2013-43A
Other languages
English (en)
Inventor
Jérôme Emile Georges Guillemont
Ismet Dorange
Magali Madeleine Simone Motte
Koenraad Jozef Lodewijk Marcel Andries
Anil Koul
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37909392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME01521(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ME01521B publication Critical patent/ME01521B/me

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

Ovaj pronalazak se odnosi na nove supstituisane kinolinske derivate u skladu sa formulom (Ia) ili (Ib):     uključujući njihove bilo koje stereohemijske izomerne forme, njihove  N -okside, farmaceutski prihvatljive soli ili rastvorljive materije.  
MEP-2013-43A 2006-12-06 2007-12-04 Antibakterijski kinolinski derivati ME01521B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06125510 2006-12-06
EP07847812A EP2099760B1 (en) 2006-12-06 2007-12-04 Antibacterial quinoline derivatives
PCT/EP2007/063314 WO2008068268A1 (en) 2006-12-06 2007-12-04 Antibacterial quinoline derivatives

Publications (1)

Publication Number Publication Date
ME01521B true ME01521B (me) 2014-04-20

Family

ID=37909392

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2013-43A ME01521B (me) 2006-12-06 2007-12-04 Antibakterijski kinolinski derivati

Country Status (31)

Country Link
US (1) US8293732B2 (me)
EP (1) EP2099760B1 (me)
JP (1) JP5466012B2 (me)
KR (3) KR101574642B1 (me)
CN (1) CN101547905B (me)
AP (1) AP2670A (me)
AR (1) AR064147A1 (me)
BR (1) BRPI0719939B8 (me)
CA (1) CA2668517C (me)
CL (1) CL2007003515A1 (me)
CY (1) CY1114384T1 (me)
DK (1) DK2099760T3 (me)
EA (1) EA022344B1 (me)
ES (1) ES2407824T3 (me)
HR (1) HRP20130372T1 (me)
IL (2) IL199078A (me)
JO (1) JO2970B1 (me)
ME (1) ME01521B (me)
MX (1) MX2009005979A (me)
MY (1) MY150411A (me)
NO (1) NO342095B1 (me)
NZ (1) NZ577128A (me)
PL (1) PL2099760T3 (me)
PT (1) PT2099760E (me)
RS (1) RS52753B (me)
SG (1) SG10201405650SA (me)
SI (1) SI2099760T1 (me)
TW (1) TWI396536B (me)
UA (1) UA101306C2 (me)
WO (1) WO2008068268A1 (me)
ZA (1) ZA200903946B (me)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2970B1 (en) * 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
CN104254528B (zh) 2012-04-27 2017-06-06 詹森药业有限公司 抗菌的喹啉衍生物
US9133167B2 (en) 2012-04-27 2015-09-15 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
EA201891644A1 (ru) * 2016-03-07 2019-04-30 Зе Глобал Эллайенс Фо Тб Драг Девелопмент, Инк. Антибактериальные соединения и их применение
WO2018048882A1 (en) 2016-09-06 2018-03-15 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for bacterial infection

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001503411A (ja) 1996-10-28 2001-03-13 ディパートメント オブ ジ アーミー，ユー．エス．ガバメント 抗生物質耐性感染症の処置のための化合物、組成物および方法
US6103905A (en) 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
RS52431B (sr) * 2002-07-25 2013-02-28 Janssen Pharmaceutica N.V. Derivati hinolina i njihova upotreba kao mikobakterijskih inhibitora
EP1711492B1 (en) 2004-01-23 2008-04-16 Janssen Pharmaceutica N.V. Substituted quinolines and their use as mycobacterial inhibitors
UA86952C2 (uk) 2004-01-23 2009-06-10 Янссен Фармацевтика Н.В. Похідні хіноліну та їх застосування як мікобактеріальних інгібіторів
CN1910154B (zh) 2004-01-29 2011-08-17 詹森药业有限公司 用作分枝杆菌抑制剂的喹啉衍生物
ES2306146T3 (es) * 2004-05-28 2008-11-01 Janssen Pharmaceutica Nv Uso de derivados de quinolina sustituidos para el tratamiento de enfermedades micobacterianas resistentes a farmacos.
DK1797115T3 (en) 2004-09-28 2017-10-02 Janssen Pharmaceutica Nv BACTERIAL ATP SYNTHASE BINDING DOMAIN.
EE05394B1 (et) * 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
CA2528849C (en) 2005-06-08 2014-01-14 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents
JO2752B1 (en) 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
AP2547A (en) 2005-06-28 2012-12-26 Janssen Pharmaceutica Nv Quinoline derivatives as antibacterial agents
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2970B1 (en) * 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives

Also Published As

Publication number Publication date
BRPI0719939B8 (pt) 2021-05-25
EA200970536A1 (ru) 2009-10-30
TWI396536B (zh) 2013-05-21
PT2099760E (pt) 2013-05-06
RS52753B (sr) 2013-08-30
KR20150126737A (ko) 2015-11-12
CN101547905B (zh) 2015-01-28
US20100029679A1 (en) 2010-02-04
IL199078A (en) 2015-10-29
HK1137433A1 (en) 2010-07-30
BRPI0719939A2 (pt) 2014-03-11
UA101306C2 (en) 2013-03-25
KR101908350B1 (ko) 2018-10-16
IL241548A0 (en) 2015-11-30
DK2099760T3 (da) 2013-05-13
MX2009005979A (es) 2009-06-16
CN101547905A (zh) 2009-09-30
CL2007003515A1 (es) 2008-07-11
NZ577128A (en) 2012-01-12
EA022344B1 (ru) 2015-12-30
PL2099760T3 (pl) 2013-07-31
CY1114384T1 (el) 2016-08-31
JP5466012B2 (ja) 2014-04-09
TW200838530A (en) 2008-10-01
MY150411A (en) 2014-01-15
JP2010511669A (ja) 2010-04-15
AP2009004871A0 (en) 2009-06-30
CA2668517A1 (en) 2008-06-12
WO2008068268A1 (en) 2008-06-12
KR20170003741A (ko) 2017-01-09
EP2099760A1 (en) 2009-09-16
JO2970B1 (en) 2016-03-15
CA2668517C (en) 2016-01-12
KR101574642B1 (ko) 2015-12-04
BRPI0719939B1 (pt) 2020-11-17
SI2099760T1 (sl) 2013-06-28
AU2007328888A1 (en) 2008-06-12
AP2670A (en) 2013-05-15
SG10201405650SA (en) 2014-11-27
HRP20130372T1 (en) 2013-05-31
ES2407824T3 (es) 2013-06-14
US8293732B2 (en) 2012-10-23
NO20092536L (no) 2009-08-24
AR064147A1 (es) 2009-03-18
NO342095B1 (no) 2018-03-19
ZA200903946B (en) 2010-08-25
IL241548B (en) 2018-03-29
KR20090090339A (ko) 2009-08-25
EP2099760B1 (en) 2013-02-20

Similar Documents

Publication Publication Date Title
NO20072963L (no) 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
NO20083630L (no) Nye pyridinderivater
UA107791C2 (en) Pesticidal compositions
NO20091395L (no) Nye tiofenderivater
ES2531093T3 (es) Procedimiento de preparación de halogenuros de N-alquil-naltrexona
MX2010003001A (es) Derivados de quinolina como antagonistas del receptor de la 5-hidroxitriptamina 5a.
CR20140316A (es) Derivados de indol como antagonistas receptores de s1p1 (divisional 10922)
MX2010004576A (es) Derivados de pirimidina novedosos.
HRP20120323T1 (en) Diarylhydantoin compounds
DK1881967T3 (da) Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika
WO2009156462A3 (en) Organic compounds
WO2008022286A3 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
MX2008014004A (es) 1h-benzimidazol-4-carboxamidas sustituidas son inhibidores de parp potentes.
EA200601391A1 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
MXPA05013474A (es) Derivados de quinolilamida como antagonistas de ccr-5.
TW200600494A (en) Bisphenyl compounds useful as vitamin d3 receptor agonists
EP2154290A4 (en) SCHOTTERSTOPFARBEITEN, BACHING
TW200740814A (en) Compounds
ME01521B (me) Antibakterijski kinolinski derivati
UA94603C2 (ru) Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления
MX2007011847A (es) Derivados de pirimidindiona como antagonistas del receptor de procineticina 2.
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
WO2008111096A3 (en) Novel prodrugs
MX2009008028A (es) Agentes antiparasitarios.